Clinical Guidelines

MENU

Cervical cancer screening

Supplement: Sample reports

GUIDELINE UPDATES - This guideline was last updated 8/15/2018

UPCOMING GUIDELINES - This guideline was updated and comes into practice on 7/1/2022Download PDF

Author(s):

Sample cervical screening reports

CERVICAL SCREENINGLOW RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATIONRescreen in five years.


CERVICAL SCREENINGUNSATISFACTORY
SPECIMENCervical – SurePath
TEST RESULTSPCR for Oncogenic HPV and genotype: Unsatisfactory
RECOMMENDATIONRetest within six weeks.


CERVICAL SCREENINGUNSATISFACTORY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Image assisted:
Unsatisfactory

RECOMMENDATIONRepeat screening test in six weeks.


CERVICAL SCREENINGINTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Manually Read:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATIONRepeat test in 12 months.


CERVICAL SCREENINGINTERMEDIATE RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Image Assisted:
Low grade intra-epithelial lesion (LSIL)
Endocervical component: Present

RECOMMENDATIONRepeat test in 12 months.


CERVICAL SCREENINGHIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC), Manually Read:
High grade squamous intra-epithelial lesion (HSIL)
Endocervical component: Present

RECOMMENDATIONReferral for Colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC), Manually Read:
Unsatisfactory

RECOMMENDATIONReferral for Colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Image Assisted:
Possible high grade squamous intra-epithelial lesion (pHSIL)
Endocervical component: Not identified

RECOMMENDATIONReferral for Colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK FOR SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Manually Read:
High grade squamous intra-epithelial lesion (HSIL)
Endocervical component: Not identified

RECOMMENDATIONReferral for Colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC), Image Assisted:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATIONReferral for Colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Manually Read:
There is no evidence of a squamous intraepithelial lesion or malignancy
Endocervical component: Present

RECOMMENDATIONIn view of the previously reported abnormality referral for colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Image Assisted:
Low grade squamous intra-epithelial lesion (LSIL)
Endocervical component: Present

RECOMMENDATIONIn view of the previously reported abnormality referral for colposcopic assessment.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected

Liquid Based Cytology (LBC), Manually Read:
Atypical endocervical cells of undetermined significance
There is no evidence of a squamous intraepithelial lesion or malignancy

RECOMMENDATIONReferral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC), Image Assisted:
Possible high grade glandular lesion
The findings suggest possible adenocarcinoma-in-situ

RECOMMENDATIONReferral for colposcopic assessment by a gynaecologist with expertise in the evaluation of suspected malignancies or by a gynaecological oncologist.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – ThinPrep
TEST RESULTS

PCR for High Risk HPV and genotype:

  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC) Image Assisted:
Squamous cell carcinoma
There are abnormal cells that indicate origin from an invasive squamous cell carcinoma Endocervical component: Present

RECOMMENDATIONColposcopy is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENCervical – SurePath
TEST RESULTS

PCR for High Risk HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Detected
  • HPV (not 16/18) – Not detected

Liquid Based Cytology (LBC), Manually Read:
Endocervical adenocarcinoma

RECOMMENDATIONColposcopy is recommended. Patient should be referred to a gynaecological oncologist or a gynaecological cancer centre for assessment.


Sample stand alone LBC reports

SPECIMENCervical – SurePath
TEST RESULTS

Liquid Based Cytology (LBC) Manually Read:


Low grade squamous intra-epithelial lesion (LSIL)
Endocervical component: Present

RECOMMENDATIONThis woman is under specialist management, therefore no management recommendation is made.


SPECIMENCervical – ThinPrep
TEST RESULTS

Liquid Based Cytology (LBC) Image assisted:


High grade squamous intra-epithelial lesion (HSIL)
Endocervical component: Present

RECOMMENDATIONThis woman is under specialist management, therefore no management recommendation is made.

Reports for self-collected samples

CERVICAL SCREENINGLOW RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENLower vaginal sample – Self collected
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATIONRescreen in five years.


CERVICAL SCREENING
SPECIMENLower vaginal sample – Self collected
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Not detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Detected
RECOMMENDATIONCollect a cervical sample for LBC within six weeks.


CERVICAL SCREENINGHIGHER RISK OF SIGNIFICANT CERVICAL ABNORMALITY
SPECIMENLower vaginal sample – Self collected
TEST RESULTS

PCR for Oncogenic HPV and genotype:

  • HPV 16 – Detected
  • HPV 18 – Not detected
  • HPV (not 16/18) – Not detected
RECOMMENDATIONRefer for colposcopic assessment. Cervical sample for LBC can be obtained at time of that assessment.

WEBSITE UPDATES - This website was last updated 5/18/2022

Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.
Acknowledgement Image Title
Cancer Council Australia